Labs / CDMO: development & manufacturing

Sinopep-Allsino Biopharmaceutical Co., Ltd.
Hangzhou, China · sinopep.com
GLP · GMP · FDA registered
Sinopep-Allsino Biopharmaceutical Co., Ltd. develops and manufactures peptides, oligonucleotides, small molecules, and related conjugates for research, development, clinical, and commercial programs. It serves qualified research and pharmaceutical organizations from China, with facilities in Jiangsu Lianyungang and other operations supporting global clients.
They take quote requests through a form on their website with project details. Their quote form
What they offer
Custom Peptide Synthesis
Synthesizes custom research-grade peptides for discovery research and project-specific sequences.
Custom Oligo Synthesis
Produces custom oligonucleotides including ASO, siRNA, miRNA, PMO, aptamer, CpG, and decoy oligos.
Conjugate Synthesis
Makes peptide, small-molecule, and oligo conjugates such as POCs and PPMOs.
FTE Services
Provides a full-time-equivalent model with dedicated personnel assigned to client projects for a fixed period.
Peptide CDMO Services
Provides end-to-end CMC development and cGMP manufacturing of peptide APIs from early development through commercialization.
Oligo CDMO Services
Provides end-to-end oligonucleotide manufacturing from research-grade to clinical-grade material.
Formulation Services
Develops finished dosage forms including oral solid dosage forms, lyophilized powder injections, and small-volume injections.
Generic APIs
Develops and manufactures peptide, oligo, and small molecule active pharmaceutical ingredients.
What they work on
- Modalities
- Small molecule, Peptide, Oligonucleotide
- Assays and studies
- RP-HPLC, MS, IEX, IP-RP-HPLC, forced degradation, impurity profiling, stability studies, analytical method development, analytical method validation
- Instruments and platforms
- solid-phase peptide synthesis (SPPS) platforms, liquid-phase peptide synthesis (LPPS) platforms, Distributed Control System (DCS), real-time PAT, dynamic axial compression columns
- Scale and capacity
- peptide capacity of 20–30 metric tons annually, oligonucleotide manufacturing capacity of 1,000 kg annually, PMO capacity of 100 kg annually, peptide-oligo conjugate capacity of 200 kg annually, production up to hundreds of kilograms, SPPS reactors up to 3,000 L, LPPS reactors up to 10,000 L, dynamic axial compression columns up to 1,200 mm
- What to send
- Sequence in three- or one-letter format · Quantity selection for research peptide quote · Structure file upload optional
- Type
- CRDMO
- Sites
- Jiangsu Lianyungang, China
- Quality
- FDA/ICH guidelines (peptide CDMO services) · U.S. FDA inspections (passed four inspections since 2009) · FDA & EMA compliant (formulation facilities) · GMP (manufacturing facilities) · global regulatory requirements (manufacturing facilities in the United States, European Union, China, and Japan)
- Serves
- global, United States, European Union, China, Japan
- Address
- 1378 Wenyi West Road, Yuhang District, Hangzhou City, Zhejiang 311121, China
- Founded
- 2009
Public records
Similar labs. Porton, WuXi STA, VxP Biologics, ARSI Canada Inc
Found in a contract services directory. Listing built from sinopep.com. Work here? Claim this listing.